¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"drugs toxic to lung"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® parenteral administration of drugs ÇÑ±Û ºñ°æ±¸Àû ¾àǰÅõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù.
  
  1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇϴ °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù.
  
  2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼­ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁַΠ¾Ë·¯Áö È¯ÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù.
  
  3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, È¤Àº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁַΠÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª È¤Àº ÃµÃµÈ÷ ÀÛ¿ëÇϴ ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù.
  
  4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» Áִ ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù.
  
  5) ¼ö¸·°­³»ÁÖ»ç: intrathecal injection-µÎ°³³ª Ã´¼ö°­³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù.
  
  6)°­³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°­³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù.
¿µ¹® heart-lung machine ÇÑ±Û ½ÉÀå-ÇãÆÄ ±â°è
¼³¸í   
  ½ÉÀåÀÇ ¼ö¼ú¿¡ »ç¿ëµÇ´Â ±â°è·Î¼­ ½ÉÀåÀÌ ¼ö¼úÀ» ¹Þ°í Àִ µ¿¾È ±â´ÉÀ» ÇÏÁö ¸øÇϹǷΠÀÌ ±â´ÉÀ» ´ë½Å ÇØÁִ ±â°èÀÌ´Ù. À̰ÍÀº ´ëÁ¤¸Æ°ú ´ëµ¿¸Æ»çÀÌ¿¡ ¿¬°áÀÌ µÇ¾î¼­ Ç÷¾×À» °­Á¦·Î ¼øÈ¯½ÃŰ¸é¼­ ´ëÁ¤¸Æ¿¡¼­ ¿Â ÇÇ¿¡ »ê¼Ò¸¦ °ø±ÞÇÏ¿© ´ëµ¿¸ÆÀ¸·Î µ¹·Á º¸³»´Â ¿ªÇÒÀ» ÇÑ´Ù. Áï ½ÉÀå°ú ÆóÀÇ ¿ªÇÒÀ» µ¿½Ã¿¡ Çϴ ±â°èÀÌ´Ù.
¿µ¹® rectal administration of drugs ÇÑ±Û ¾à¹°ÀÇ °ðâÀÚÁ¾à½Ä Åõ¿©
¼³¸í   
  ÀÔÀ» ÅëÇØ ¸ÔÀº ¾à¹°Àº Èí¼öµÈ ÈÄ °£À» °ÅÃÄ º´º¯ºÎÀ§·Î ¿î¹ÝµÈ´Ù. µû¶ó¼­ °£¿¡¼­ ´ë»ç°¡ µÇ¾î ¾à¹°·Î¼­ÀÇ È¿°ú°¡ ¾ø¾îÁú °¡´É¼ºÀÌ ÀÖÀ» »Ó ¾Æ´Ï¶ó °£¿¡ µ¶¼ºÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼öµµ ÀÖ´Ù. ÀÌ·¯ÇÑ ´ÜÁ¡À» º¸¿ÏÇϱâÀ§ÇØ °£À» ÅëÇÏÁö ¾Ê°í À绡¸® Èí¼öµÇ¾î º´º¯À¸·Î °¥ ¼ö Àִ ¹æÆíÀ¸·Î Á÷ÀåÁ¾àÀ» »ç¿ëÇÑ´Ù. Á÷ÀåÀÇ Á¤¸ÆÈ帧Àº °£À» °ÅÄ¡Áö ¾Ê°í Á÷Á¢ ÇÏ´ëÁ¤¸ÆÀ» ÅëÇØ ¿ì½É¹æÀ¸·Î Èê·¯µé±â ¶§¹®ÀÌ´Ù. 
¿µ¹® side effects of drugs ÇÑ±Û ¾à¹°ÀÇ ºÎÀÛ¿ë
¼³¸í   
  ¾àÀ» »ç¿ëÇÒ ¶§ ±â´ëÇϴ ȿ°ú ¿Ü¿¡ ´Ù¸¥ Àå±â¿¡¼­ ³ªÅ¸³ª´Â ¿øÄ¡ ¾Ê´Â È¿°ú¸¦ ÃÑĪÇϴ ¸»ÀÌ´Ù. ¿¹¸¦ µé¾î Ç÷¾ÐÀ» ³·Ãß±â À§ÇØ Ç×°íÇ÷¾ÐÁ¦¸¦ »ç¿ë ½Ã, Ç÷¾ÐÀÌ ¶³¾îÁö´Â µ¿½Ã¿¡ ±â°üÁöÀÇ ¼öÃàÀÌ ÀϾ´Â Çö»ó.
¿µ¹® total lung capacity ÇÑ±Û ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
¼³¸í   
  ÆóȰ·®(°¡´ÉÇÑ ÇÑ ±í°Ô µé¿© ¸¶½Å ½ÃÁ¡ºÎÅ͠õõÈ÷ ÇѲ¯ ³»½® ¿ë·®)¿¡ Àܱⷮ(ÃÖ´ë ³¯¼ûÀ§Ä¡¿¡¼­ Æó³»¿¡ ³²Àº ¿ë·®. ¾à 1,200mL)À» ÇÕÇÑ °ÍÀÌ´Ù. °Ç°­ÇÑ ¼ºÀÎÀº 6,000~7,000mL. Æó±âÁ¾, ¸¸¼º ±â°üÁö¿° µîÀÇ Æó»ö¼º Àå¾Ö·Î Áõ°¡ÇϰԠµÇ´Â ÇÑÆí ÇãÆÄ¼¶À¯Áõ, ¹«±âÆó, Èä¼ö, Èä°ûº¯Çü µîÀÇ ±¸¼Ó¼º Àå¾Ö·Î °¨¼ÒÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • streptococcal toxic shock syndrome
    »ç½½¾Ë±Õµ¶¼º¼îÅ©ÁõÈıº, ¿¬¼â±¸±Õµ¶¼º¼îÅ©ÁõÈıº
  • apex of lung
    ÇãÆÄ²À´ë±â, Æó²À´ë±â
  • artificial heart-lung apparatus
    Àΰø½ÉÀåÆóÀåÄ¡, Àΰø½ÉÀåÇãÆÄÀåÄ¡
  • air conditioner lung
    ¿¡¾îÄÁÆó, ¿¡¾îÄÁÇãÆÄ
  • bauxite lung
    º¸Å©»çÀÌÆ®Æó, º¸Å©»çÀÌÆ®ÇãÆÄ
  • cardiac lung
    ½É¼ºÆó, ¿ïÇ÷Æó, ½ÉÀåÅ¿ÇãÆÄ
  • drowned lung
    ÀÍ»çÆó, ÀÍ»çÇãÆÄ
  • fibroid lung
    Æó¼¶À¯Áõ, ¼¶À¯¸ð¾çÇãÆÄ
  • farmer¡¯s lung
    ³óºÎÆó, ³óºÎÇãÆÄ
  • hyperlucent lung
    °úÅõ°úÆó, °úÅõ°ú¼ºÇãÆÄ
  • heart lung ratio
    ½ÉÆóºñ
  • heart-lung machine
    Àΰø½ÉÆó±â
  • honeycomb lung
    ¹úÁýÆó, ¹úÁýÇãÆÄ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic erythema
    Áßµ¶È«¹Ý
  • toxic nodule
    µ¶¼º°áÀý
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • toxic substance
    µ¶¼º¹°Áú
  • artificial heart-lung apparatus
    Àΰø½ÉÀåÆóÀåÄ¡, Àΰø½ÉÀåÇãÆÄÀåÄ¡
  • open lung biopsy
    °³¹æÆó»ý°Ë
  • static lung compliance
    Á¤ÀûÆóź¼º, Á¤ÀûÇãÆÄź¼º, Á¤ÀûÆóÀ¯¼øµµ
  • total lung capacity
    ÃÑÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
  • lung
    Æó, ÇãÆÄ
  • lung squeeze
    Æó¾ÐÃà, ÇãÆÄ¾ÐÃà
  • lung volume
    Æó¿ëÀû, ÇãÆÄºÎÇÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apex of lung
    ÇãÆÄ²À´ë±â, Æó²À´ë±â
  • air-conditioner lung
    ¿¡¾îÄÜÇãÆÄ, ¿¡¾îÄÜÆó
  • artificial heart-lung apparatus
    Àΰø½ÉÀåÇãÆÄÀåÄ¡, Àΰø½ÉÀåÆóÀåÄ¡
  • one lung anesthesia
    ÇÑÂÊÆó¸¶Ãë, ÇÑÂÊÇãÆÄ¸¶Ãë
  • bauxite lung
    º¸Å©»çÀÌÆ®ÇãÆÄ, º¸Å©»çÀÌÆ®Æó
  • butterfly lung
    ³ªºñ¸ð¾çÇãÆÄ, ¹æ»ç³ªºñÇüÆó
  • open lung biopsy
    °³ÈäÆó»ý°Ë
  • cardiac lung
    ½ÉÀåÅ¿ÇãÆÄ, ½É¼ºÆó, ¿ïÇ÷Æó
  • small cell lung cancer
    ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï, ¼Ò¼¼Æ÷Æó¾Ï
  • total lung capacity
    ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
  • vital lung capacity
    ÆóȰ·®
  • drowned lung
    ÀÍ»çÇãÆÄ, ÀÍ»çÆó
  • dry-lung drowning
    °ÇÆóÀÍ»ç, ¸¶¸¥ÇãÆÄÀÍ»ç
  • generalized obstructive lung disease
    ¹ü¹ßÆó¼âÆóº´
  • irreversible obstructive lung disease
    ºñ°¡¿ªÆó¼âÆóº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychosis, toxic
    µ¶¹°Á¤½Åº´, Áßµ¶Á¤½Åº´.
  • artificial heart lung apparatus =artificial heart lung machine
    Àΰø½ÉÆó(ÀåÄ¡).
  • Ganglionic blocking drugs
    ½Å°æÀýÂ÷´Ü¾àÁ¦(ãêÌèï½ó´Ó¨å·ð¥)
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
  • poisoning by drugs
    ¾à¹°Áßµ¶(ËâËÑÌ¡ËÄ).
  • poisoning by drugs
    ¾à¹°Áßµ¶(å·ÚªñéÔ¸).
  • Castanedas rat lung method
    Ä«½ºÅ¸³×´Ù ¼­Æó¹ý.
  • Coffee workers lung
    Ä¿Çǰø Æó
  • Heart-lung machines
    Àΰø½ÉÆó±â(ìÑÍïãýøËÐï)
  • Left lung, interior lobe
    ¿ÞÇãÆÄ, ¾Æ·¡¿±
  • TLC => total lung capacity
    ÀüÆó¿ë·®
  • air-conditioner lung
    ¿¡¾îÄÜ Æó(¡­øË)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • artificial heart lung apparatus =artificial heart lung machine
    Àΰø½ÉÆó(ÀåÄ¡).
  • antimalarial drugs
    Ç׸»¶ó¸®¾ÆÁ¦(ù÷¡­ð¥).
  • drugs
    ¾à¹°(å·Úª)
  • drugs,interaction
    »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • drugs,overdosage
    °ú·®(ΦÕá)
  • drugs,side effects
    ºÎÀÛ¿ë(ÜùíÂéÄ)
  • drugs,therapeutic
    Ä¡·á(Àû)(ö½ÖûîÜ)
  • galenical preparation =crude drugs
    »ý¾à (ßæå·).
  • hydantoinlike drugs
    È÷´ÜÅäÀξç¾àÁ¦.
  • illict drugs
    ºÒ¹ý¾à¹°
  • official drugs ³ª officinalis remedies
    ¾àÀü¾à(å·îðå·), °øÁ¤¾à(ÍëïÒå·).
  • poisoning by drugs
    ¾à¹°Áßµ¶(ËâËÑÌ¡ËÄ).
  • poisoning by drugs
    ¾à¹°Áßµ¶(å·ÚªñéÔ¸).
  • sulfa drugs
    ¼³ÆÄÁ¦(¡­ð¥).
  • sustained action drugs
    ÁöÈ¿¼º ¾àÁ¦(ò¥üùàõ å·ð¥).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cardiac notch (of left lung)
    (¿ÞÇãÆÄ)½ÉÀåÆÐÀÓ
    [¿¾ ¿ë¾î] ½ÉÀåÀýÈç
  • Horizontal fissure [of right lung)
    ¼öÆòÆ´»õ(¿À¸¥ÇãÆÄ)
    [¿¾ ¿ë¾î] ¿ìÆó¼öÆò·Ä
  • Apex of left lung
    ¿ÞÇãÆÄ²À´ë±â
    [¿¾ ¿ë¾î] ÁÂÆó÷
  • Lingula of left lung
    ¿ÞÇãÆÄÇô
    [¿¾ ¿ë¾î] ÁÂÆó¼Ò¼³
  • Fetal lung
    žÆÇãÆÄ
    [¿¾ ¿ë¾î] ÅÂ¾ÆÆó
  • Apex of lung
    ÇãÆÄ²À´ë±â
    [¿¾ ¿ë¾î] Æó÷
  • Base of lung
    ÇãÆÄ¹Ù´Ú
    [¿¾ ¿ë¾î] ÆóÀú
  • Right lung
    ¿À¸¥ÇãÆÄ
    [¿¾ ¿ë¾î] ¿ìÆó
  • Right lung, inferior lobe
    ¿À¸¥ÇãÆÄ, ¾Æ·¡¿±
    [¿¾ ¿ë¾î] ¿ìÆó, ÇÏ¿±
  • Right lung, superior lobe
    ¿À¸¥ÇãÆÄ, À§¿±
    [¿¾ ¿ë¾î] ¿ìÆó, »ó¿±
  • Right lung, middle lobe
    ¿À¸¥ÇãÆÄ, Áß°£¿±
    [¿¾ ¿ë¾î] ¿ìÆó, Áß¿±
  • Left lung, inferior lobe
    ¿ÞÇãÆÄ, ¾Æ·¡¿±
    [¿¾ ¿ë¾î] ÁÂÆó, ÇÏ¿±
  • Middle lobe (of right lung)
    Áß°£¿±(¿À¸¥ÇãÆÄ)
    [¿¾ ¿ë¾î] ¿ìÆóÁß¿±
  • Left lung
    ¿ÞÇãÆÄ
    [¿¾ ¿ë¾î] ÁÂÆó
  • Left lung, superior lobe
    ¿ÞÇãÆÄ, À§¿±
    [¿¾ ¿ë¾î] ÁÂÆó, »ó¿±
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amebic lung abscess
    ¾Æ¸Þ¹ÙÆó³ó¾ç
  • lung fluke
    ÆóÈíÃæ
  • lung migration
    ÆóÀÌÇà
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lung surfactant
    Æó °è¸éȰ¼ºÁ¦(øËÍ£ØüüÀàõð­)
  • median toxic dose
    Á¤Áß µ¶¼º·®(ïáñéÔ¸àõÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nodular toxic goiter
    °áÀý¼ºÁßµ¶¼º°©»ó¼±Á¾
  • toxic
    µ¶¼ºÀÇ
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • farmer's lung
    ³óºÎÆó
  • heart lung machine
    ½ÉÆó±â, Àΰø½ÉÆóÀåÄ¡±â
  • heart lung ratio
    ½ÉÆó°è¼ö
  • hilum of lung
    Æó¹®
  • hypogenetic lung syndrome
    Àú¹ß»ýÆóÁõÈıº
  • idiopathic unilateral hyperlucent lung
    Ư¹ß¼ºÀÏÃø¼º°úÅõ°ú¼ºÆó
  • lung
    ÆóÀå
  • lung biopsy
    Æó»ý°Ë
  • lung field
    Æó¾ß
  • lung marking
    Æó¹«´Ì
  • lung marking
    ÆóÀ½¿µ
  • middle lung field
    Á߯ó¾ß
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TDD telecommunication device for the deaf; tetradecadiene; thoracic duct drainage; total digitalizing do...
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
DILD diffuse infiltrative lung disease; diffuse interstitial lung disease
LC Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf...
TLC tender loving care; thin-layer chromatography; total L-chain concentration; total lung capacity; tot...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ATD Antithyroid drugs
DMARD Disease Modifying Antirheumatic Drugs
NSAID Non Steroid Anti-Inflammatory Drugs
SAARD Slow Acting Anti-Rheumatic Drugs
ATSDR Agency for Toxic Substances and Disease Registry
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • allergic-toxic contact stomatitis
    ¾Ë·¯Áö-µ¶¼º Á¢ÃË ±¸³»¿°
  • nodular toxic goiter
    °áÀý¼º Áßµ¶¼º °©»ó¼±Á¾
  • toxic action
    µ¶ ÀÛ¿ë
  • toxic amblyopia
    Áßµ¶ ¾à½Ã
  • toxic damage
    µ¶¼º ¼Õ»ó
  • toxic dyspepsia
    Áßµ¶¼º ¼ÒÈ­ ºÒ·®
  • toxic effect curve
    µ¶¼º °î¼±
  • toxic fume bronchiolitis obliterans
    µ¶¼º ¿¬±â¿¡ ÀÇÇÑ Æó¼â¼º ¼¼±â°üÁö¿°
    Áú¼Ò »êÈ­¹°, Æ÷½º°ÕÀ̳ª ±âŸ À¯µ¶ °¡½º¿¡ Æø·ÎµÈ ÈÄ 1-3ÁÖ ÈÄ ¹ß»ýÇÑ´Ù. ÈäºÎ ¹æ»ç¼± »çÁø»ó ¹Ì¸¸¼º ƯÀ̼º ÆóÆ÷ ¶Ç´Â °£À¯¸® À½¿µÀ» º¸ÀδÙ.
  • toxic mucosal damage
    µ¶¼º Á¡¸· ¼Õ»ó
  • toxic myocarditis
    Áßµ¶¼º ½É±Ù¿°
  • toxic reaction
    µ¶ ¹ÝÀÀ, Áßµ¶ ¹ÝÀÀ
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • toxic uninodular goiter
    Áßµ¶¼º ´Ü°áÀý¼º °©»ó¼±Á¾
  • air-conditioner lung
    ¿¡¾îÄÜ Æó
  • apex of the lung
    Æó÷
    ÀüüÀûÀ¸·Î ¿øÃßÇüÀ» ÀÌ·é Æó ºÎÀ§ Áß »ÏÁ·ÇÑ À§ÂÊ ºÎÀ§.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
drugs toxic to lung <radiology> Bleomycin, methotrexate, cytoxan, amiodarone
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
veterinary drugs Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.
(12 Dec 1998)
cytotoxic drugs <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells.
See: chemotherapy.
(13 Nov 1997)
psychotropic drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents).
(12 Dec 1998)
neuroleptic drugs Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine.
Origin: Gr. Lepsis = a taking hold
(18 Nov 1997)
street drugs Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
(12 Dec 1998)
designer drugs Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
(12 Dec 1998)
drugs, chinese herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china.
(12 Dec 1998)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
drugs, generic Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
(12 Dec 1998)
drugs, investigational Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries.
(12 Dec 1998)
drugs, non-prescription Drugs that can be sold legally without a prescription.
(12 Dec 1998)
immunosuppressive drugs Drugs that block the bodys ability to fight infection or foreign substances that enter the body. A person receiving an organ transplant is given these drugs to stop the body from rejecting the new organ or tissue. Cyclosporin is a commonly used immunosuppressive drug.
(09 Oct 1997)
orphan drugs Drugs, biologicals, and medical devices (including diagnostic in vitro tests) that may be useful in common or rare diseases but which are not considered commercially viable.
Synonym: orphan drugs.
(05 Mar 2000)
megacolon, toxic Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon.
(12 Dec 1998)
goiter, diffuse toxic Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxic
    À¯µ¶ÇÑ
  • toxic
    (Áß)µ¶ÀÇ
  • lung
    Æó
  • black lung
    źÁøÆó
  • green lung
    (µµ½Ã³»ÀÇ)³ª¹«°¡ ÀÖ´Â ±¸¿ª;³ìÁö;°ø¿ø
  • iron lung
    öÆó(öÁ¦ÀÇ È£Èí º¸Á¶±â)
  • lung
    ¼Ò¸®°¡ Å©´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á